세계의 바이오제조 바이러스 검출 및 정량화 시장 : 제공 유형, 기술, 용도, 최종 사용자별 예측(2025-2030년)

The Biomanufacturing Viral Detection & Quantification Market was valued at USD 2.67 billion in 2023, expected to reach USD 2.89 billion in 2024, and is projected to grow at a CAGR of 8.40%, to USD 4.71 billion by 2030.

The biomanufacturing viral detection and quantification market is a significant segment within the biotechnology sector, focusing on ensuring safety and quality in biopharmaceutical production. The scope encompasses advanced biosensing technologies, including PCR, ELISA, and next-generation sequencing, which are pivotal in detecting and quantifying viral contaminants in cell cultures and biologics. The necessity for these technologies arises from stringent regulatory demands ensuring biosafety and product efficacy, particularly in the production of vaccines, gene therapies, and monoclonal antibodies. Applications primarily occur in preclinical and commercial manufacturing settings, where accurate viral detection is crucial. Key growth factors include the burgeoning biopharmaceutical industry, increased R&D investments, and technological advancements in assay development, thus presenting opportunities for companies to innovate in rapid testing methods and automated workflows. Emerging trends such as the use of AI and machine learning in predictive analytics offer promising avenues for meeting the growing demand for high-throughput, accurate, and economical solutions.

To capitalize on these opportunities, businesses should focus on developing multi-pathogen detection systems and enhancing sample preparation techniques to increase efficiency and reliability. However, challenges such as the high cost of sophisticated detection systems, lack of standardized protocols, and complexity in interpreting results could impede market expansion. Regulatory hurdles and the need for technical expertise also pose significant constraints. Nonetheless, investing in collaborative R&D and partnerships can mitigate these barriers, fostering innovation and market penetration. The market presents a dynamic landscape with a focus on precision, speed, and cost-effectiveness. Companies that stay adaptable to evolving regulatory standards and technological advancements, while engaging in strong stakeholder collaborations, can effectively navigate challenges and leverage growth opportunities in the highly competitive market of biomanufacturing viral detection and quantification.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomanufacturing Viral Detection & Quantification Market

The Biomanufacturing Viral Detection & Quantification Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of viral diseases and need for enhanced detection techniques
  • Exponential investments in drug development and manufacturing processes
  • Growing demand for portable and point-of-care vital testing
• Market Restraints
  • Lack of skilled personnel and high cost of quantification devices
• Market Opportunities
  • Rapid advancements in viral testing and quantification methods
  • Emphasis on environmental monitoring of viral contaminants
• Market Challenges
  • Technical difficulties associated with the isolation of viral load

Porter's Five Forces: A Strategic Tool for Navigating the Biomanufacturing Viral Detection & Quantification Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomanufacturing Viral Detection & Quantification Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomanufacturing Viral Detection & Quantification Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomanufacturing Viral Detection & Quantification Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomanufacturing Viral Detection & Quantification Market

A detailed market share analysis in the Biomanufacturing Viral Detection & Quantification Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomanufacturing Viral Detection & Quantification Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomanufacturing Viral Detection & Quantification Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomanufacturing Viral Detection & Quantification Market

A strategic analysis of the Biomanufacturing Viral Detection & Quantification Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomanufacturing Viral Detection & Quantification Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Charles River Laboratories, Danaher Corporation, Genscript Biotech Corporation, Hamilton Company, Illumina, Inc., LG Chem, Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Recipharm AB, Sartorius AG, Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Thomas Scientific LLC, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Biomanufacturing Viral Detection & Quantification Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering Type, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Accessories and Kits & Assays.
• Based on Technology, market is studied across Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay, and Polymerase Chain Reaction.
• Based on Application, market is studied across Blood & Blood Products Manufacturing, Cellular & Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue & Tissue Products Manufacturing, and Vaccines & Therapeutics Manufacturing.
• Based on End User, market is studied across CROs & CDMOs, Life Science Companies, and Testing Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of viral diseases and need for enhanced detection techniques
    • 5.1.1.2. Exponential investments in drug development and manufacturing processes
    • 5.1.1.3. Growing demand for portable and point-of-care vital testing
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled personnel and high cost of quantification devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Rapid advancements in viral testing and quantification methods
    • 5.1.3.2. Emphasis on environmental monitoring of viral contaminants
  • 5.1.4. Challenges
    • 5.1.4.1. Technical difficulties associated with the isolation of viral load
• 5.2. Market Segmentation Analysis
  • 5.2.1. Offering Type: Advances in consumables for high accuracy
  • 5.2.2. Technology: Improved adoption of PCR technique for high specificity
  • 5.2.3. Application: Surging applications in vaccines & therapeutics manufacturing
  • 5.2.4. End User: Rising adoption from CROs and CDMOs for viral quantification
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biomanufacturing Viral Detection & Quantification Market, by Offering Type

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Accessories
  • 6.2.2. Kits & Assays
• 6.3. Instruments
• 6.4. Services

7. Biomanufacturing Viral Detection & Quantification Market, by Technology

• 7.1. Introduction
• 7.2. Enzyme-Linked Immunosorbent Assay
• 7.3. Flow Cytometry
• 7.4. Plaque Assay
• 7.5. Polymerase Chain Reaction

8. Biomanufacturing Viral Detection & Quantification Market, by Application

• 8.1. Introduction
• 8.2. Blood & Blood Products Manufacturing
• 8.3. Cellular & Gene Therapy Products Manufacturing
• 8.4. Stem Cell Products Manufacturing
• 8.5. Tissue & Tissue Products Manufacturing
• 8.6. Vaccines & Therapeutics Manufacturing

9. Biomanufacturing Viral Detection & Quantification Market, by End User

• 9.1. Introduction
• 9.2. CROs & CDMOs
• 9.3. Life Science Companies
• 9.4. Testing Laboratories

10. Americas Biomanufacturing Viral Detection & Quantification Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biomanufacturing Viral Detection & Quantification Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biomanufacturing Viral Detection & Quantification Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Launch of DNAllergen Real-time PCR Kits for the Reliable Detection Of Target Allergen Sequences
  • 13.3.2. Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
  • 13.3.3. New BGI Genomics Fluorescent RT-PCR Kit Approved for COVID-19, Influenza A & B Detection in Australia
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. BASF SE
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. bioMerieux SA
• 6. Charles River Laboratories
• 7. Danaher Corporation
• 8. Genscript Biotech Corporation
• 9. Hamilton Company
• 10. Illumina, Inc.
• 11. LG Chem, Ltd.
• 12. Lonza Group Ltd.
• 13. Merck KGaA
• 14. New England Biolabs
• 15. Norgen Biotek Corp.
• 16. Oxford Nanopore Technologies PLC
• 17. PerkinElmer, Inc.
• 18. Promega Corporation
• 19. QIAGEN N.V.
• 20. Recipharm AB
• 21. Sartorius AG
• 22. Shimadzu Corporation
• 23. Takara Bio Inc.
• 24. Thermo Fisher Scientific Inc.
• 25. Thomas Scientific LLC
• 26. Zymo Research Corporation